145 related articles for article (PubMed ID: 2681396)
1. Autoantibodies and antigens in liver diseases--updated.
Manns M
J Hepatol; 1989 Sep; 9(2):272-80. PubMed ID: 2681396
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune liver diseases.
Manns MP; Nakamura RM
Clin Lab Med; 1988 Jun; 8(2):281-301. PubMed ID: 3284697
[TBL] [Abstract][Full Text] [Related]
3. [The diagnostic value of immunologic findings in the differentiation of chronic liver diseases].
Manns M; Meyer zum Büschenfelde KH; Arnold W
Leber Magen Darm; 1988 Dec; 18(6):290-2, 295, 298 passim. PubMed ID: 3063910
[TBL] [Abstract][Full Text] [Related]
4. Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques.
Gruber R; Felber E; Pape GR; Höchtlen-Vollmar W; Riethmüller G
J Clin Lab Anal; 1994; 8(5):284-92. PubMed ID: 7807283
[TBL] [Abstract][Full Text] [Related]
5. [Immunology of liver diseases].
Meyer zum Büschenfelde KH
Schweiz Med Wochenschr; 1987 Jul; 117(29):1065-75. PubMed ID: 3313682
[TBL] [Abstract][Full Text] [Related]
6. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
7. [The association between autoantibodies to enzyme and diseases--with special reference to antibodies to pyruvate dehydrogenase complex (PDH)].
Moteki S; Amaki S; Nakano E
Rinsho Byori; 1998 Apr; 46(4):317-23. PubMed ID: 9594621
[TBL] [Abstract][Full Text] [Related]
8. Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex.
Fregeau DR; Davis PA; Danner DJ; Ansari A; Coppel RL; Dickson ER; Gershwin ME
J Immunol; 1989 Jun; 142(11):3815-20. PubMed ID: 2715637
[TBL] [Abstract][Full Text] [Related]
9. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
10. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.
Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME
Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis.
Van de Water J; Ansari AA; Surh CD; Coppel R; Roche T; Bonkovsky H; Kaplan M; Gershwin ME
J Immunol; 1991 Jan; 146(1):89-94. PubMed ID: 1984455
[TBL] [Abstract][Full Text] [Related]
12. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.
Strassburg CP; Alex B; Zindy F; Gerken G; Lüttig B; Meyer zum Büschenfelde KH; Bréchot C; Manns MP
J Hepatol; 1996 Dec; 25(6):859-66. PubMed ID: 9007714
[TBL] [Abstract][Full Text] [Related]
13. Occurrence and significance of IgG liver membrane autoantibodies (LMA) in chronic liver diseases of different aetiology.
Meliconi R; Stancari MV; Garagnani M; Baraldini M; Stefanini GF; Miglio F; Gasbarrini G
Clin Exp Immunol; 1983 Mar; 51(3):565-71. PubMed ID: 6342885
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.
Nishio A; Van de Water J; Leung PS; Joplin R; Neuberger JM; Lake J; Björkland A; Tötterman TH; Peters M; Worman HJ; Ansari AA; Coppel RL; Gershwin ME
Hepatology; 1997 May; 25(5):1085-9. PubMed ID: 9141421
[TBL] [Abstract][Full Text] [Related]
15. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis.
Reynoso-Paz S; Leung PS; Van De Water J; Tanaka A; Munoz S; Bass N; Lindor K; Donald PJ; Coppel RL; Ansari AA; Gershwin ME
Hepatology; 2000 Jan; 31(1):24-9. PubMed ID: 10613723
[TBL] [Abstract][Full Text] [Related]
17. [Immunoserologic differentiation of chronic cholestatic hepatitis. Significance of antimitochondrial antibodies and hepatic membrane antibodies].
Hopf U; Möller B; Lobeck H; Klein R; Berg PA
Dtsch Med Wochenschr; 1985 Dec; 110(50):1924-9. PubMed ID: 3908047
[TBL] [Abstract][Full Text] [Related]
18. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex.
Moteki S; Leung PS; Dickson ER; Van Thiel DH; Galperin C; Buch T; Alarcon-Segovia D; Kershenobich D; Kawano K; Coppel RL
Hepatology; 1996 Mar; 23(3):436-44. PubMed ID: 8617422
[TBL] [Abstract][Full Text] [Related]
19. Comparative epitope mapping of murine monoclonal and human autoantibodies to human PDH-E2, the major mitochondrial autoantigen of primary biliary cirrhosis.
Surh CD; Ahmed-Ansari A; Gershwin ME
J Immunol; 1990 Apr; 144(7):2647-52. PubMed ID: 1690773
[TBL] [Abstract][Full Text] [Related]
20. [Immunological characteristics of primary biliary cirrhosis patients].
Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
